Positive Effects of CRISPR-Cas9 Gene Editing for Dyslipidemia Endure Through 1 Year - Cleveland Clinic
Positive Effects of CRISPR-Cas9 Gene Editing for Dyslipidemia Endure Through 1 Year Cleveland Clinic
Positive Effects of CRISPR-Cas9 Gene Editing for Dyslipidemia Endure Through 1 Year Cleveland Clinic
An Experimental Single-Time Treatment Slashed Cholesterol for a Year The New York Times
Snipping a gene to reduce bad cholesterol for life looks possible CNN
Swiss Biotech Nerai Bioscience Develops AI-Powered High-Throughput Protein Engineering for Novel CRISPR Gene Editing Tools | Top 100 Swiss Innovations 36 Kr
Gene Editing for Lipids: 1-Year CTX310 Data, With Luke Laffin, MD HCPLive
An Experimental One-Time Treatment for High Cholesterol Shows Promising Results Time Magazine
Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely and Continuously Lower Cholesterol and Triglycerides After One Year Cleveland Clinic Newsroom
Next-Generation CRISPR tools transform gene editing and gene therapy News-Medical
CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026 GlobeNewswire
News: CMN Weekly (28 August 2026) - Your Weekly CRISPR Medicine News CRISPR Medicine News
CRISPR Gene Editing Creates Hypoallergenic Dogs the-scientist.com
#ESC26: CRISPR Therapeutics to pursue highest dose of its lipid lowering gene editing therapy Endpoints News
Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety STAT
CRISPR roadblocks: Scientists identify genes blocking gene therapy success Phys.org
Fur Real: Biotech Startup Eliminates Major Dog Allergen in Beagle Pups Using CRISPR Genetic Engineering and Biotechnology News
Decoding the role of chromatin context in the off-target effects of CRISPR gene editing with EGOLD Nature
CRISPR gene-editing for crops: Precision tool or new risk? DW.com
CTX310 Gene Editing Sustains ANGPTL3, LDL Reductions at 1 Year HCPLive
Brain-directed gene editing ends in death CRISPR Medicine News
Founder, Jens-Ole Bock, CMN, Keynote Speaker at the CRISPR Gene Editing Hands-on Workshop at University of Lagos, Nigeria CRISPR Medicine News
CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia Nature
China Agricultural University researchers develop novel type I-C CRISPR systems for genome editing in plants EurekAlert!
CRISPR-Cas9-Mediated Gene Editing in Hematological Disorders: Advancing Translational and Clinical Applications Cureus
CRISPR Shreds Undruggable Cancer Cells with Precision Genetic Engineering and Biotechnology News
SMArT Platform Improves Safety and Efficiency of CRISPR Editing in HSPCs Inside Precision Medicine
Children’s Hospital of Philadelphia Marks One-Year Anniversary of World’s First Personalized CRISPR Gene Therapy for Child with Rare Genetic Disease Children's Hospital of Philadelphia
CRISPR Therapeutics cuts LDL cholesterol by half with one gene edit, lasting 1 year DongA Science
Standardizing Personalized CRISPR Gene-Editing Therapies Genetic Engineering and Biotechnology News
Therapeutic applications of CRISPR-Cas9 gene editing Frontiers
Gene Editing Therapy in Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology JACC Journals
Editas Medicine stock holds steady as investors weigh latest gene editing progress AD HOC NEWS
Viral genome editing methods and applications in the CRISPR era ASM Journals
Cutting to the chase with CRISPR HDBuzz
New SMArT platform improves safety of CRISPR gene editing News-Medical
Gene-edited beagles may offer a future option for people with dog allergies AP News
A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics Yahoo Finance
Scientists Edit Human Embryo Genes With Startling Precision The New York Times
Compact CRISPR system unlocks targeted in-body gene editing, with up to 90% efficiency Phys.org
New kind of CRISPR could treat viral infection and cancer by shredding sick cells’ DNA The University of Utah
Mayo Clinic Joins a $27.7 Million Federal Push to Build One Gene Editing Platform for Rare Immune Disease Medical Daily